These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

709 related articles for article (PubMed ID: 26291921)

  • 1. Cancer stem cells and the tumor microenvironment: interplay in tumor heterogeneity.
    Albini A; Bruno A; Gallo C; Pajardi G; Noonan DM; Dallaglio K
    Connect Tissue Res; 2015; 56(5):414-25. PubMed ID: 26291921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic dormancy: a complex network between cancer stem cells and their microenvironment.
    Bleau AM; Agliano A; Larzabal L; de Aberasturi AL; Calvo A
    Histol Histopathol; 2014 Dec; 29(12):1499-510. PubMed ID: 24887025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.
    Eun K; Ham SW; Kim H
    BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis.
    Iqbal W; Alkarim S; AlHejin A; Mukhtar H; Saini KS
    Oncotarget; 2016 Nov; 7(46):76337-76353. PubMed ID: 27486983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor microenvironment for cancer stem cells.
    Kise K; Kinugasa-Katayama Y; Takakura N
    Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):197-205. PubMed ID: 26362921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune responses to human cancer stem-like cells/cancer-initiating cells.
    Hirohashi Y; Torigoe T; Tsukahara T; Kanaseki T; Kochin V; Sato N
    Cancer Sci; 2016 Jan; 107(1):12-7. PubMed ID: 26440127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor dormancy and cancer stem cells: two sides of the same coin?
    Kleffel S; Schatton T
    Adv Exp Med Biol; 2013; 734():145-79. PubMed ID: 23143979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microenvironmental Modulation of Decorin and Lumican in Temozolomide-Resistant Glioblastoma and Neuroblastoma Cancer Stem-Like Cells.
    Farace C; Oliver JA; Melguizo C; Alvarez P; Bandiera P; Rama AR; Malaguarnera G; Ortiz R; Madeddu R; Prados J
    PLoS One; 2015; 10(7):e0134111. PubMed ID: 26230845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment.
    López de Andrés J; Griñán-Lisón C; Jiménez G; Marchal JA
    J Hematol Oncol; 2020 Oct; 13(1):136. PubMed ID: 33059744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat shock protein DNAJB8 is a novel target for immunotherapy of colon cancer-initiating cells.
    Morita R; Nishizawa S; Torigoe T; Takahashi A; Tamura Y; Tsukahara T; Kanaseki T; Sokolovskaya A; Kochin V; Kondo T; Hashino S; Asaka M; Hara I; Hirohashi Y; Sato N
    Cancer Sci; 2014 Apr; 105(4):389-95. PubMed ID: 24450541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor and its microenvironment: a synergistic interplay.
    Catalano V; Turdo A; Di Franco S; Dieli F; Todaro M; Stassi G
    Semin Cancer Biol; 2013 Dec; 23(6 Pt B):522-32. PubMed ID: 24012661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation and transdifferentiation potentials of cancer stem cells.
    Huang Z; Wu T; Liu AY; Ouyang G
    Oncotarget; 2015 Nov; 6(37):39550-63. PubMed ID: 26474460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concepts of metastasis in flux: the stromal progression model.
    Sleeman JP; Christofori G; Fodde R; Collard JG; Berx G; Decraene C; Rüegg C
    Semin Cancer Biol; 2012 Jun; 22(3):174-86. PubMed ID: 22374376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular matrix-mediated regulation of cancer stem cells and chemoresistance.
    Brown Y; Hua S; Tanwar PS
    Int J Biochem Cell Biol; 2019 Apr; 109():90-104. PubMed ID: 30743057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune checkpoints in tumor microenvironment and their relevance to the development of cancer stem cells.
    Khosravi N; Mokhtarzadeh A; Baghbanzadeh A; Hajiasgharzadeh K; Shahgoli VK; Hemmat N; Safarzadeh E; Baradaran B
    Life Sci; 2020 Sep; 256():118005. PubMed ID: 32593711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Resistance Driven by Cancer Stem Cells and Their Niche.
    Prieto-Vila M; Takahashi RU; Usuba W; Kohama I; Ochiya T
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer stem cells--the current status of an old concept: literature review and clinical approaches.
    Fulawka L; Donizy P; Halon A
    Biol Res; 2014 Dec; 47(1):66. PubMed ID: 25723910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
    Yan Y; Zuo X; Wei D
    Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow-derived fibrocytes promote stem cell-like properties of lung cancer cells.
    Saijo A; Goto H; Nakano M; Mitsuhashi A; Aono Y; Hanibuchi M; Ogawa H; Uehara H; Kondo K; Nishioka Y
    Cancer Lett; 2018 May; 421():17-27. PubMed ID: 29448000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial plasticity, cancer stem cells, and the tumor-supportive stroma in bladder carcinoma.
    van der Horst G; Bos L; van der Pluijm G
    Mol Cancer Res; 2012 Aug; 10(8):995-1009. PubMed ID: 22714124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.